Kiran Turaga

Yale University · University of Chicago

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers in pancreatic cancer

PubMed author-name match

Trials

Studies that name Kiran Turaga as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:18 UTC. Open this list on ClinicalTrials.gov

N/A
NCT07291180 · A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis
Yale University · recruiting · Appendiceal Cancer, Colorectal Adenocarcinoma, Peritoneal Metastases · principal investigator
Ph2
NCT07282912 · Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Yale University · recruiting · Foregut Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Adenocarcinoma · principal investigator
Ph2
NCT05041062 · A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma
University of Chicago · completed · Mesothelioma, Peritoneal Mesothelioma · principal investigator
Ph2
NCT04931420 · Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
University of Chicago · withdrawn · Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma · principal investigator
N/A
NCT02359994 · Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
Artivion Inc. · completed · Blood Loss, Surgical · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in pancreatic cancer.